Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma

被引：0
|
作者：
Sakai, Chio [1 ]
Matsuyama, Masashi [1 ]
Nakajima, Masayuki [1 ]
Matsumura, Sosuke [1 ]
Nonaka, Mizu [1 ]
Arai, Naoki [1 ]
Kuramoto, Kenya [1 ]
Yoshida, Kazufumi [1 ]
Morishima, Yuko [1 ]
Muratani, Masafumi [2 ]
Hizawa, Nobuyuki [1 ]
机构：
[1] Univ Tsukuba, Fac Med, Dept Pulm Med, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan
[2] Univ Tsukuba, Fac Med, Dept Genome Biol, Ibaraki, Japan
来源：
ALLERGOLOGY INTERNATIONAL | 2024年 / 73卷 / 03期
关键词：
D O I：
10.1016/j.alit.2024.03.005
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：473 / 476
页数：4
相关论文
共 50 条
  • [31] Real life data on treatment response to mepolizumab in patients with severe eosinophilic asthma
    Ntakoula, M.
    Fokoloros, C.
    Pasali, M.
    Aggelides, X.
    Makris, M.
    ALLERGY, 2019, 74 : 446 - 446
  • [32] Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use
    Albers, Frank C.
    Hozawa, Soichiro
    Bratton, Daniel J.
    Yancey, Steven W.
    Prazma, Charlene M.
    Humbert, Marc
    Liu, Mark C.
    ALLERGY, 2020, 75 (04) : 942 - 946
  • [33] Mepolizumab (Nucala) for Severe Eosinophilic Asthma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1486): : 11 - 12
  • [34] Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype
    Domvri, Kalliopi
    Tsiouprou, Ioanna
    Bakakos, Petros
    Steiropoulos, Paschalis
    Katsoulis, Konstantinos
    Kostikas, Konstantinos
    Antoniou, Katerina M.
    Papaioannou, Andriana I.
    Rovina, Nikoletta
    Katsaounou, Paraskevi
    Papamitsou, Theodora
    Pastelli, Nicoleta
    Tryfon, Stavros
    Fouka, Evangelia
    Papakosta, Despoina
    Loukides, Stelios
    Porpodis, Konstantinos
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02) : 425 - 435
  • [35] Real-life treatment of severe eosinophilic asthma with mepolizumab
    Pelaia, Corrado
    Busceti, Maria Teresa
    Solinas, Sabina
    Terracciano, Rosa
    Pelaia, Girolamo
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [36] Mepolizumab in real-life treatment of severe eosinophilic asthma
    Volakova, Eva
    Zatloukal, Jaromir
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [37] A nursing protocol for mepolizumab administration in the treatment of eosinophilic severe asthma
    Rojas Crespo, A.
    Lopez Onieva, M.
    De La Torre Gaspar, Vazquez M.
    Blanca Lopez, N.
    Hernandez Coello, A., I
    Costo Romero, N.
    Rodriguez Alcantara, M., V
    Ramos Vital, C.
    Rodriguez Martinez, M. A.
    Canto Diez, G.
    ALLERGY, 2018, 73 : 826 - 826
  • [38] Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma
    Ortega, Hector
    Katz, Lynn
    Hartley, Benjamin
    Yancey, Steve
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [39] Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
    Shimoda, Terufumi
    Odajima, Hiroshi
    Okamasa, Arisa
    Kawase, Minako
    Komatsubara, Masaki
    Mayer, Bhabita
    Yancey, Steven
    Ortega, Hector
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (03) : 445 - 451
  • [40] Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
    Takanori Numata
    Katsutoshi Nakayama
    Hirofumi Utsumi
    Kenji Kobayashi
    Haruhiko Yanagisawa
    Mitsuo Hashimoto
    Shunsuke Minagawa
    Takeo Ishikawa
    Hiromichi Hara
    Jun Araya
    Kazuyoshi Kuwano
    BMC Pulmonary Medicine, 19
12345